Tezcan, G. Et Al. 2017. Olea europaea leaf extract and bevacizumab synergistically exhibit beneficial efficacy upon human glioblastoma cancer stem cells through reducing angiogenesis and invasion in vitro. BIOMEDICINE & PHARMACOTHERAPY , vol.90 , 713-723.

Tezcan, G., Taşkapılıoğlu, M. Ö., Tunca, B., Bekar, A., Demirci, H., Kocaeli, H., ... Aksoy, S.(2017). Olea europaea leaf extract and bevacizumab synergistically exhibit beneficial efficacy upon human glioblastoma cancer stem cells through reducing angiogenesis and invasion in vitro. BIOMEDICINE & PHARMACOTHERAPY , vol.90, 713-723.

Tezcan, GÜLÇİN Et Al. "Olea europaea leaf extract and bevacizumab synergistically exhibit beneficial efficacy upon human glioblastoma cancer stem cells through reducing angiogenesis and invasion in vitro," BIOMEDICINE & PHARMACOTHERAPY , vol.90, 713-723, 2017

Tezcan, GÜLÇİN Et Al. "Olea europaea leaf extract and bevacizumab synergistically exhibit beneficial efficacy upon human glioblastoma cancer stem cells through reducing angiogenesis and invasion in vitro." BIOMEDICINE & PHARMACOTHERAPY , vol.90, pp.713-723, 2017

Tezcan, G. Et Al. (2017) . "Olea europaea leaf extract and bevacizumab synergistically exhibit beneficial efficacy upon human glioblastoma cancer stem cells through reducing angiogenesis and invasion in vitro." BIOMEDICINE & PHARMACOTHERAPY , vol.90, pp.713-723.

@article{article, author={GÜLÇİN TEZCAN Et Al. }, title={Olea europaea leaf extract and bevacizumab synergistically exhibit beneficial efficacy upon human glioblastoma cancer stem cells through reducing angiogenesis and invasion in vitro}, journal={BIOMEDICINE & PHARMACOTHERAPY}, year=2017, pages={713-723} }